With a projected market for regenerative medicine of $500 billion by 2020 in the U.S. alone, states are right to fund economic programs targeting stem cell research and biotechnology, but politicians can’t be short-sighted by demanding short-term payoffs.
Stem cell research can spur economic growth, researcher says
